Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate for Comorbid AUD and PTSD
NCT03667846Phase 2Recruiting
- Sponsor
- NYU Langone Health
- Start
- Oct 2019
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in alcohol use disorder (AUD) and post-traumatic stress disorder (PTSD) comparing Topiramate with Placebo (2 arms). Primary endpoints: Timeline Follow-back at Day 1, Percent Days Abstinent from Alcohol at Week 12 and 1 more. Started Oct 2019; status: recruiting.
02
Drugs
topiramate
03
Conditions
alcohol use disorder (AUD)post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT03667846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03667846.